tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Appili Therapeutics Secures New Patents for LIKMEZ, Strengthening Market Position
Company AnnouncementsAppili Therapeutics Secures New Patents for LIKMEZ, Strengthening Market Position
2d ago
Appili Therapeutics granted new patents for LIKMEZ
PremiumThe Fly
Appili Therapeutics granted new patents for LIKMEZ
2d ago
Appili Therapeutics CEO to Discuss Strategic Growth and Funding Initiatives
PremiumCompany Announcements
Appili Therapeutics CEO to Discuss Strategic Growth and Funding Initiatives
28d ago
Appili Therapeutics CEO to join Aditxt CEO for weekly update on April 4
PremiumThe Fly
Appili Therapeutics CEO to join Aditxt CEO for weekly update on April 4
28d ago
ADTX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
PLX
SLS
Appili Therapeutics Seeks $117.5 Million in Federal Funding for Infectious Disease Treatments
PremiumCompany AnnouncementsAppili Therapeutics Seeks $117.5 Million in Federal Funding for Infectious Disease Treatments
1M ago
Appili Therapeutics announces submission of government funding proposals
Premium
The Fly
Appili Therapeutics announces submission of government funding proposals
1M ago
Appili Therapeutics expects Aditxt transaction to close in Q1
Premium
The Fly
Appili Therapeutics expects Aditxt transaction to close in Q1
1M ago
ADTX
Appili Therapeutics Advances Pipeline with Strong Shareholder and Government Support
PremiumCompany Announcements
Appili Therapeutics Advances Pipeline with Strong Shareholder and Government Support
2M ago
Appili Therapeutics Moves Forward with Aditxt Acquisition
PremiumCompany Announcements
Appili Therapeutics Moves Forward with Aditxt Acquisition
5M ago
Appili Therapeutics Highlights Progress and Shareholder Support
PremiumCompany Announcements
Appili Therapeutics Highlights Progress and Shareholder Support
6M ago
Appili Therapeutics reports Q2 EPS (C$0.01) vs. (C$0.01) last year
PremiumThe Fly
Appili Therapeutics reports Q2 EPS (C$0.01) vs. (C$0.01) last year
6M ago
Appili Therapeutics shareholders vote in favor of Aditxt transaction
PremiumThe FlyAppili Therapeutics shareholders vote in favor of Aditxt transaction
6M ago
ADTX
Appili Shareholders Approve Acquisition by Aditxt
Premium
Company Announcements
Appili Shareholders Approve Acquisition by Aditxt
6M ago
Aditxt announces ‘positive’ FDA feedback for Appili Therapeutics ATI-1801
Premium
The Fly
Aditxt announces ‘positive’ FDA feedback for Appili Therapeutics ATI-1801
6M ago
ADTX
Appili Therapeutics’ FDA Alignment and Aditxt Acquisition
PremiumCompany Announcements
Appili Therapeutics’ FDA Alignment and Aditxt Acquisition
6M ago
Appili Therapeutics announces FDA alignment on ATI-1801 NDA requirements
PremiumThe Fly
Appili Therapeutics announces FDA alignment on ATI-1801 NDA requirements
6M ago
ADTX
Appili Updates on Tularemia Vaccine Progress
PremiumCompany Announcements
Appili Updates on Tularemia Vaccine Progress
6M ago
Appili Therapeutics presents update on ATI-1701 biodefense vaccine candidate
PremiumThe Fly
Appili Therapeutics presents update on ATI-1701 biodefense vaccine candidate
7M ago
Appili Therapeutics Corrects Shareholder Payout Terms
PremiumCompany AnnouncementsAppili Therapeutics Corrects Shareholder Payout Terms
7M ago
Appili Therapeutics Nears Acquisition by Aditxt Inc.
Premium
Company Announcements
Appili Therapeutics Nears Acquisition by Aditxt Inc.
7M ago
Appili Therapeutics mails circular in connection with special meeting
Premium
The Fly
Appili Therapeutics mails circular in connection with special meeting
7M ago
ADTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >